Clearside Biomedical Inc (CLSD)
1.29
+0.02
(+1.57%)
USD |
NASDAQ |
May 01, 11:39
Clearside Biomedical Total Assets (Quarterly): 34.02M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 34.02M |
| September 30, 2023 | 34.42M |
| June 30, 2023 | 39.18M |
| March 31, 2023 | 44.70M |
| December 31, 2022 | 51.30M |
| September 30, 2022 | 55.68M |
| June 30, 2022 | 30.75M |
| March 31, 2022 | 36.06M |
| December 31, 2021 | 42.90M |
| September 30, 2021 | 27.38M |
| June 30, 2021 | 28.59M |
| March 31, 2021 | 27.82M |
| December 31, 2020 | 19.32M |
| September 30, 2020 | 17.40M |
| June 30, 2020 | 17.74M |
| March 31, 2020 | 25.04M |
| December 31, 2019 | 26.78M |
| September 30, 2019 | 25.87M |
| Date | Value |
|---|---|
| June 30, 2019 | 29.85M |
| March 31, 2019 | 37.53M |
| December 31, 2018 | 44.12M |
| September 30, 2018 | 69.38M |
| June 30, 2018 | 88.02M |
| March 31, 2018 | 104.46M |
| December 31, 2017 | 40.49M |
| September 30, 2017 | 54.88M |
| June 30, 2017 | 68.42M |
| March 31, 2017 | 81.96M |
| December 31, 2016 | 84.81M |
| September 30, 2016 | 57.77M |
| June 30, 2016 | 56.16M |
| March 31, 2016 | 16.91M |
| December 31, 2015 | 21.06M |
| September 30, 2015 | 4.516M |
| December 31, 2014 | 10.30M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
17.40M
Minimum
Sep 2020
55.68M
Maximum
Sep 2022
32.36M
Average
29.85M
Median
Jun 2019
Total Assets (Quarterly) Benchmarks
| Cassava Sciences Inc | 151.66M |
| Heron Therapeutics Inc | 222.51M |
| Actinium Pharmaceuticals Inc | 81.44M |
| Karyopharm Therapeutics Inc | 240.44M |
| Ocular Therapeutix Inc | 252.06M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 49.93M |
| Shareholders Equity (Quarterly) | -15.91M |
| Current Ratio | 4.421 |